Kiniksa Pharmaceuticals International (KNSA) Change in Receivables (2021 - 2026)
Kiniksa Pharmaceuticals International (KNSA) posted Change in Receivables of $266,000 for Q2 2026, compared with -$8.16 million a year earlier and down 96.5% from the prior quarter.
Powered by 
Analysis
Kiniksa Pharmaceuticals International (KNSA) Change in Receivables (2021 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Change in Receivables at Kiniksa Pharmaceuticals International was -$8.42 million; for FY2025, it came in at -$26.13 million.
- In prior years, Kiniksa Pharmaceuticals International's Change in Receivables was $20.46 million in FY2024 (+137.7%), $8.61 million in FY2023 (-0.8%), $8.68 million in FY2022 (+121.9%) and $3.91 million in FY2021.
- Quarterly Change in Receivables has run from a low of -$36.15 million in Q4 2025 to a high of $25.46 million in Q1 2022 over five years.
- According to Business Quant data, Change in Receivables for the three prior quarters was $7.63 million (Q1 2026), -$36.15 million (Q4 2025) and $19.83 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.35 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.37 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.09 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 333.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 140.20 Mn |
| 10 | Kiniksa Pharmaceuticals International | 11.64 Bn | 10.38 Bn | 220.03 Mn | 266,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 266,000.00 |
| Mar 31, 2026 | 7.63 Mn |
| Dec 31, 2025 | -36.15 Mn |
| Sep 30, 2025 | 19.83 Mn |
| Jun 30, 2025 | -8.16 Mn |
| Mar 31, 2025 | -1.66 Mn |
| Dec 31, 2024 | 16.84 Mn |
| Sep 30, 2024 | 4.44 Mn |
| Jun 30, 2024 | 4.46 Mn |
| Mar 31, 2024 | -5.27 Mn |
| Dec 31, 2023 | 18.23 Mn |
| Sep 30, 2023 | -21.61 Mn |
| Jun 30, 2023 | 17.23 Mn |
| Mar 31, 2023 | -5.24 Mn |
| Dec 31, 2022 | 1.50 Mn |
| Sep 30, 2022 | 3.35 Mn |
| Jun 30, 2022 | -21.63 Mn |
| Mar 31, 2022 | 25.46 Mn |
| Dec 31, 2021 | 686,000.00 |
| Sep 30, 2021 | 673,000.00 |
API Access
Kiniksa Pharmaceuticals International Change in Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-receivables&ticker=KNSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-receivables", "ticker": "KNSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-receivables&ticker=KNSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();